How can research inform the development of evidence-based approaches to treating chronic pain?

May 10, 2021 ... We report the findings of a randomized, double-blind, placebo-controlled, multi-site phase 3 clinical trial (NCT03537014) to test the efficacy ... In this short-term study, romiplostim increased platelet counts in 88% of children with ITP and was well-tolerated and apparently safe. Seizures were controlled in 89% of the episodes treated with lorazepam and in 76% treated with diazepam. The times for onset of action of the medications did ... Dihydroergotamine nasal spray during migraine attacks: A double blind crossover study with placebo ... double-blind study. Cephalgia. 1984; 4:107-111. The purpose of this research trial is to investigate the effects of LY3437943 (drug) compared with placebo on renal function, in participants who are ... A double-blind, placebo-controlled, randomized study was performed to determine whether proglumide added to ongoing neuroleptic medication was efficacious ... Sep 3, 2024 ... This is a randomized, placebo-controlled, double-blind multicenter, phase 2a study assessing the safety, pharmacokinetics (what the body does to ... Jun 14, 2022 ... Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy Feb 21, 1980 ... Controlled Double-Blind Study of the Effect of Rifampin on Humoral and Cellular Immune Responses in Patients with Pulmonary Tuberculosis and ... In a double-blind study, neither the patients nor the researchers/doctors know which study group the patients are in. In a triple-blind study, the patients ...